Tradestie Institutional Equity Comparison Engine
ARIA vs AGEN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AGEN Overall Edge
AGEN Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Agenus Inc. (AGEN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ARIA trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus AGEN at 3.7x Forward P/E and 38.9% operating margin (+4.1% YoY). In options structure, ARIA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AGEN sits in BREAKDOWN (13th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
AGEN
ARIA N/M vs AGEN 3.7x Fwd P/E
Growth & Margin Winner
AGEN
Op Margin N/A vs 38.9% ยท YoY N/A vs +4.1%
Momentum & Technical Winner
AGEN
1Y -17.0% vs +45.3% ยท 52W Pos 0% vs 47%
Options & Structure Winner
AGEN
UNCLASSIFIED (N/A IV) vs BREAKDOWN (13th %ile IV)
ARIA
US Equity
ARIA
Institutional Equity
$21.03
-3.52% 1D
Market Cap
N/A
1M Return
-11.55%
1Y Return
-16.97%
Forward P/E
N/M
Unified AI Score
47.7 / 100
HOLD
Tech 50.0
Fund 52.0
Flow 50.0
Mom 60.0
AGEN
NASDAQ
Agenus Inc.
Biological Products, (No Disgnostic Substances)
$6.29
-6.54% 1D
Market Cap
$304.5M
1M Return
+4.14%
1Y Return
+45.27%
Forward P/E
3.7x
Unified AI Score
52.4 / 100
HOLD
Tech 44.0
Fund 53.0
Flow 66.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ARIA -16.97%
AGEN +45.27%
Spread: +6.83 pp (AGEN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ARIA TTM Op. Margin: N/A
AGEN TTM Op. Margin: 38.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ARIA vs AGEN. Trailing 12-month operating profitability (ARIA N/A vs AGEN 38.9%) and valuation multiples (ARIA N/M vs AGEN 3.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ARIA | AGEN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $304.5M | Larger Scale | AGEN |
| Trailing P/E Ratio Valuation | N/M | 29.3x | Lower Multiple | AGEN |
| Forward P/E Ratio Valuation | N/M | 3.7x | Lower Multiple | AGEN |
| Revenue Growth (YoY) Growth | N/A | +4.1% | Higher Growth | AGEN |
| Operating Margin (TTM) Profitability | N/A | 38.9% | Higher Margin | AGEN |
| Net Profit Margin Profitability | N/A | 30.8% | Higher Margin | AGEN |
| Return on Equity (ROE) Capital Efficiency | N/A | -1278.8% | Higher ROE | AGEN |
| 52-Week Range Position Momentum | 0% ($21โ$27) | 47% ($3โ$10) | Stronger Trend | AGEN |
| Beta / 30D Volatility Risk Regime | 1.92ฮฒ ยท 43% Vol | 1.61ฮฒ ยท 76% Vol | Lower Realized Risk | ARIA |
| Unified Institutional Score Composite Signal | 47.7 / 100 (HOLD) | 52.4 / 100 (HOLD) | Higher Composite | AGEN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ARIA vs AGEN Buy Guide
ARIA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
AGEN
BREAKDOWN
33d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
13th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ARIA nor AGEN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.